Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Ayala Pharmaceuticals

Ayala Pharmaceuticals

Series B
Tel Aviv, IsraelFounded 2017Apr 2019

Ayala Pharmaceuticals raised €27M in a Series B round in Apr 2019. The company is based in Tel Aviv, Israel. Investors in the round: Novartis Venture Fund. Data as of Nov 2026.

← Ayala Pharmaceuticals
Amount raised
€27M
€26,702,270
Native amount
30,000,000 USD
Stage
Series B
series b
Investors
1

Provenance & confidence

High confidence
Amount
30,000,000 USD
ECB-at-date → €27M · rate 1.1235 on 2019-03-29
High confidence
Source

nocamels.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Novartis Venture Fund
Date
Apr 2019
Round type
series b
Amount (EUR)
€27M

Other rounds

same company

This is the company's only recorded round.

Related news